Baxter was forced to halt production for nearly two months after the historic storm, until a temporary structure was put in ...

The global Infusion Pump Market, valued at US$18.5 billion in 2024 stood at US$19.9 billion in 2025 and is projected to advance at a ...

According to the latest study from BCC Research, the global market for Intravenous (IV) Therapy and Vein Access is projected ...

Baxter's Q1 adjusted EPS of $0.62 topped ... driven by strong demand for IV infusion pumps and nutrition therapies, particularly in the United States; and solid performance in the Advanced Surgery ...

Baxter International reported sales and net ... with strong growth from infusion therapies driven by strong demand for IV infusion pumps and nutrition therapies, the release said.

Infusion Pumps In our opinion ... Injectable Therapies Also in its legacy product set, Baxter sells a variety of IV solutions, nutritional products, and generic pharmaceuticals.

Braun Infusomat primary lines and the current provincial contracted Baxter secondary lines," the memo states. The lines, or tubes, are hooked up to an IV pump which delivers fluids or doses of ...

Baxter International has been in the healthcare market for almost 100 years, since 1931, when it bgan manufacturing prepared IV solutions ... a nurse call, a pump, a monitor, a dashboard, a ...

Baxter International ended 2024 on a positive note, overcoming challenges posed by Hurricane Helene and delivering better-than-expected Q4 results. The success of the Novum IQ infusion pump ...

These include sterile IV solutions ... Management estimates that Baxter International Inc. maintains approximately 70% market share in Infusion Pumps and IVs. Infusion Pump sales in 2023 were ...

Infusion Pumps In our opinion ... Injectable Therapies Also in its legacy product set, Baxter sells a variety of IV solutions, nutritional products, and generic pharmaceuticals.